# TADALAFIL
> **ANDA210329** · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2026-05-15
## Drug
- **FDA Application Number:** ANDA210329
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TADALAFIL
- **Generic name:** Tadalafil
- **Active ingredients:** TADALAFIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JUBILANT GENERICS
- **First approval:** 2026-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210329)
---
*MORVS · CC0 1.0*